Reduction of human blood asparagine by hemodialysis.
D000328:Adult; D000970:Antineoplastic Agents; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use; D001216:Asparagine / Q000097:blood*; D002675:Child, Preschool; D002813:Chondrosarcoma / Q000628:therapy; D002854:Chromatography, Paper; D002986:Clinical Trials as Topic; D004298:Dopamine / Q000652:urine; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D007945:Leukemia, Lymphoid / Q000628:therapy; D008297:Male; D009455:Neurofibroma / Q000628:therapy; D009647:Normetanephrine / Q000652:urine; D006435:Renal Dialysis; D012509:Sarcoma / Q000628:therapy; D013237:Stereoisomerism; D014642:Vanilmandelic Acid / Q000652:urine
D000970:Antineoplastic Agents; D009647:Normetanephrine; D014642:Vanilmandelic Acid; D001216:Asparagine; D001215:Asparaginase; D004298:Dopamine